Heim600664 • SHA
add
Harbin Pharmaceutical Group Co., Ltd.
Við síðustu lokun
3,64 ¥
Árabil
2,41 ¥ - 4,13 ¥
Markaðsvirði
9,49 ma. CNY
Meðalmagn
35,52 m.
V/H-hlutf.
16,19
A/V-hlutfall
-
Aðalkauphöll
SHA
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (CNY) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 4,00 ma. | 6,05% |
Rekstrarkostnaður | 977,13 m. | 23,80% |
Nettótekjur | 166,64 m. | 175,81% |
Hagnaðarhlutfall | 4,17 | 160,62% |
Hagnaður á hvern hlut | — | — |
EBITDA | 274,38 m. | 50,36% |
Virkt skatthlutfall | 22,99% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (CNY) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 3,18 ma. | 22,51% |
Heildareignir | 14,24 ma. | 3,68% |
Heildarskuldir | 8,48 ma. | -0,98% |
Eigið fé alls | 5,76 ma. | — |
Útistandandi hlutabréf | 2,52 ma. | — |
Eiginfjárgengi | 1,82 | — |
Arðsemi eigna | 3,80% | — |
Ávöxtun eigin fjár | 7,00% | — |
Peningaflæði
Breyting á handbæru fé
| (CNY) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 166,64 m. | 175,81% |
Handbært fé frá rekstri | 344,42 m. | -1,27% |
Reiðufé frá fjárfestingum | -15,62 m. | -70,10% |
Reiðufé frá fjármögnun | 15,19 m. | 115,53% |
Breyting á handbæru fé | 344,23 m. | 40,80% |
Frjálst peningaflæði | 377,94 m. | 6,99% |
Um
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Stofnsett
1988
Vefsvæði
Starfsfólk
9.853
